Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

A move toward self-medication in the United States

Cal Woodward
CMAJ July 10, 2012 184 (10) 1130-1131; DOI: https://doi.org/10.1503/cmaj.109-4220
Cal Woodward
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Call it do-it-yourself medicine. A range of diagnostic and treatment decisions now rooted in the doctor’s office will shift to patients if the United States government follows through on a proposal to sell many prescription drugs over the counter. This has set off alarm bells in some corners of health care, though others love the idea.

Supporters of the proposal argue that self-medication can be safe with certain restricted drugs if patients are given the right information and pharmacists are trained to step up in place of doctors in carefully managed circumstances. Below-the-radar maladies often go untreated, they say, because people avoid the bother, cost or stress of a doctor’s appointment for conditions that could be readily relieved if more meds were available without a doctor’s directive.

“I strongly believe that medicine needs to take medical care to where the patients are,” says Janet Woodcock, director of the Center for Drug Evaluation and Research at the US Food and Drug Administration (FDA).

The FDA is the lead agency proposing the idea of lifting prescription restrictions on certain drugs used for diabetes, asthma, migraines, hypertension, illicit-drug overdoses and more. The agency says it would craft a list of specific pharmaceuticals but has not yet done so, although its federal registry notice indicated it could include epinephrine, anti-hypertensives and all diabetes medications (www.gpo.gov/fdsys/pkg/FR-2012-02-28/pdf/2012-4597.pdf).

To skeptics, that’s like letting passengers fly the plane with flight attendants looking over their shoulder and the pilot nowhere in sight.

“Chilling and a little scary,” Dr. Bobby Quentin Lanier, executive director of the American College of Allergy, Asthma and Immunology, told the FDA’s hearing on the matter. “Now let me say we’re not Luddites. We know change is inevitable. But we want the change to be better. And what we envision, with hearing some of the issues today, is chaos.”

Over the decades, various drugs have migrated to nonprescription status and become more widely used, from fluoride to antifungals. Self-treatment advocates say many lives have been saved by making smoking-cessation aids available over the counter. They also believe treatment would reach many of the estimated seven million Americans with undiagnosed diabetes if easier pathways to drugs were established.

As envisioned by the FDA, information kiosks at pharmacies and user-friendly computer algorithms online would walk people through questionnaires helping them determine if they need a drug or should visit a doctor. Pharmacists are key players — the only health care professionals patients would need to consult in most cases. In some instances, an initial doctor’s visit would be required, but not follow-ups to remain on a medication.

Robb McGory, pharmacy director at the Indian River Medical Center in Vero Beach, Florida, welcomes the initiative even if there are many unresolved questions about how it might unfold. “Years ago, patients started going to nurse-practitioners who had diagnostic capabilities,” he says. “The pharmacist is stepping into that role. We are going through a time of change, legally and professionally. We are expected to do more than fill a prescription.”

Figure

Self-diagnosis is a risky foundation on which to base the use of pharmaceuticals, critics say of the United States Food and Drug Administration’s proposal to create a new category of drugs for diabetes, asthma, migraines, hypertension and other diseases.

Image courtesy of © 2012 Thinkstock

Among the questions is who pays for the drugs. Both the private health insurance industry and government coverage for the elderly and the poor typically pay for prescription drugs, with other meds coming out of pocket. The new category of drugs is likely to fall into the latter group, which makes it appealing to politicians and health administrators. Cutting doctors out of some diagnoses may save the health system considerable money, shifting more costs to patients.

Dr. Richard Milsten, a urologist and member of the Indian River Medical Center Foundation board, says patients will likely diagnose themselves based solely on symptoms, without regard to other nuances that physicians utilize, such as physical appearance and examination findings.

“Patients will be right many times in their diagnosis, but I think there will be a significant error rate as well,” Milsten says. “When you hear hoof beats, it is usually a horse; but every now and then it will be a raging bull. I think some patients are going to get trampled by their own misdiagnosis resulting in a delay in accurate diagnosis. This will result in prolonged suffering or worse.”

With more than 30 million people expected to gain health insurance as a result of President Barack Obama’s health reforms, moving some into self-diagnosis and self-medication mode would not only reduce costs and strain on primary care facilities but, in theory, free doctors from some of the burdens of routine care and give them more time for complex cases.

But the American Medical Association isn’t keen on any plan that sidelines doctors, suggesting that personalized medical information from a computer is not the same as personal care from a physician. The risks of dispensing drugs without a prescription can include a failure to detect a disease’s progression or the need for changes in dosage.

Others have countered that there are dangers in the status quo which point to the need to make drugs more accessible, including the tendency for people with certain conditions, such as chronic diseases, to leave therapy at alarmingly high rates.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 184 (10)
CMAJ
Vol. 184, Issue 10
10 Jul 2012
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A move toward self-medication in the United States
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A move toward self-medication in the United States
Cal Woodward
CMAJ Jul 2012, 184 (10) 1130-1131; DOI: 10.1503/cmaj.109-4220

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A move toward self-medication in the United States
Cal Woodward
CMAJ Jul 2012, 184 (10) 1130-1131; DOI: 10.1503/cmaj.109-4220
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What to know about Omicron XBB.1.5
  • Could a flu shot push help curb pediatric hospitalizations?
  • Stalemate: What’s holding up a new health accord?
Show more News

Similar Articles

Collections

  • Topics
    • Drug regulation

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire